01 1Concord Biotech
01 1SIROLIMUS
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-08-18
Pay. Date : 2017-07-17
DMF Number : 24468
Submission : 2011-02-24
Status : Active
Type : II
20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SIROLIMUS, with a corresponding US DMF Number 24468.
Remarkably, this DMF maintains an Active status since its submission on February 24, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 18, 2017, and payment made on July 17, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
